ES518511A0 - Un procedimiento para la preparacion de compuestos dotados de propiedades psicotropicas. - Google Patents
Un procedimiento para la preparacion de compuestos dotados de propiedades psicotropicas.Info
- Publication number
- ES518511A0 ES518511A0 ES518511A ES518511A ES518511A0 ES 518511 A0 ES518511 A0 ES 518511A0 ES 518511 A ES518511 A ES 518511A ES 518511 A ES518511 A ES 518511A ES 518511 A0 ES518511 A0 ES 518511A0
- Authority
- ES
- Spain
- Prior art keywords
- procedure
- preparation
- compounds given
- psychotropic properties
- psychotropic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
- C07C55/02—Dicarboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/86—Oxygen atoms
- C07D211/88—Oxygen atoms attached in positions 2 and 6, e.g. glutarimide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/84—Nitriles
- C07D213/85—Nitriles in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/334,689 US4361565A (en) | 1981-12-28 | 1981-12-28 | 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyridines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES8402832A1 ES8402832A1 (es) | 1984-03-01 |
| ES518511A0 true ES518511A0 (es) | 1984-03-01 |
Family
ID=23308356
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES518511A Granted ES518511A0 (es) | 1981-12-28 | 1982-12-23 | Un procedimiento para la preparacion de compuestos dotados de propiedades psicotropicas. |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US4361565A (es) |
| JP (1) | JPS58118583A (es) |
| KR (1) | KR880002011B1 (es) |
| AT (1) | AT380880B (es) |
| AU (1) | AU560667B2 (es) |
| BE (1) | BE895505A (es) |
| CA (1) | CA1237722A (es) |
| CH (1) | CH653682A5 (es) |
| CY (1) | CY1378A (es) |
| DE (1) | DE3248138A1 (es) |
| DK (1) | DK162284C (es) |
| ES (1) | ES518511A0 (es) |
| FI (1) | FI70892C (es) |
| FR (1) | FR2518994B1 (es) |
| GB (1) | GB2114121B (es) |
| GR (1) | GR77101B (es) |
| HK (1) | HK5188A (es) |
| HU (1) | HU190827B (es) |
| IE (1) | IE54620B1 (es) |
| IT (1) | IT1158040B (es) |
| KE (1) | KE3714A (es) |
| LU (1) | LU84562A1 (es) |
| NL (1) | NL8204974A (es) |
| PT (1) | PT76037B (es) |
| SE (1) | SE449748B (es) |
| SG (1) | SG29687G (es) |
| ZA (1) | ZA828546B (es) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT387221B (de) * | 1980-09-08 | 1988-12-27 | Bristol Myers Co | Verfahren zur herstellung des neuen |
| AT387773B (de) * | 1983-09-12 | 1989-03-10 | Bristol Myers Co | Verfahren zur herstellung von 1-heteroaryl-4-((2,5-pyrrolidindion-1-yl)aklyl) iperazin-derivaten |
| US4524206A (en) * | 1983-09-12 | 1985-06-18 | Mead Johnson & Company | 1-Heteroaryl-4-(2,5-pyrrolidinedion-1-yl)alkyl)piperazine derivatives |
| US4619930A (en) * | 1985-01-16 | 1986-10-28 | Bristol-Myers Company | Antipsychotic cyclic imide derivatives of 2-(4-butylpiperazin-1-yl)pyridines, compositions and use |
| CA1278792C (en) * | 1985-05-06 | 1991-01-08 | Joseph P. Yevich | Antipsychotic fused-ring pyridinylpiperazine derivatives |
| US4677104A (en) * | 1985-05-06 | 1987-06-30 | Bristol-Myers Company | Antipsychotic fused-ring pyridinylpiperazine derivatives |
| US4757073A (en) * | 1986-09-30 | 1988-07-12 | Bristol-Myers Company | Antipsychotic cyclic imide derivatives of 2-(4-butylipiperazin-1-yl) pyridines, compositions and use |
| US4855430A (en) * | 1987-11-12 | 1989-08-08 | American Home Products Corporation | Polycyclicamine with psychotropic activity |
| EP0348460A4 (en) * | 1987-11-12 | 1991-11-27 | American Home Products Corporation | Polycyclicamines with psychotropic activity |
| US4880930A (en) * | 1987-11-30 | 1989-11-14 | New James S | Psychotropic acyclic amide derivatives |
| US5116970A (en) * | 1988-02-18 | 1992-05-26 | New James S | Psychotropic heterobicycloalkylpiperazine derivatives: 2. fused pyridazinones |
| US5001130A (en) * | 1988-02-18 | 1991-03-19 | Bristol-Myers Company | Psychotropic heterobicycloalkylpiperazine derivatives |
| US5098904A (en) * | 1990-06-27 | 1992-03-24 | Bristol-Myers Squibb Company | Cerebral function enhancing pyrimidinyl derivatives |
| DK0482696T3 (da) * | 1990-10-23 | 1996-05-20 | Akzo Nobel Nv | 4-(4- eller 6-(trifluormethyl-2-pyridinyl))-1-piperazinylalkyl-substituerede lactamer |
| EP0564520A1 (en) * | 1990-12-24 | 1993-10-13 | Merrell Dow Pharmaceuticals Inc. | Use of certain glutarimide derivatives in the treatment of depression and mania |
| SE9201138D0 (sv) * | 1992-04-09 | 1992-04-09 | Astra Ab | Novel phthalimidoalkylpiperazines |
| US7045519B2 (en) | 1998-06-19 | 2006-05-16 | Chiron Corporation | Inhibitors of glycogen synthase kinase 3 |
| ATE274510T1 (de) | 1998-06-19 | 2004-09-15 | Chiron Corp | Glycogen synthase kinase 3 inhibitoren |
| CA2686525C (en) * | 2007-03-29 | 2012-05-29 | Obschestvo S Ogranishennoi Otvetstvennostu "Farmving" | An antihistamine antiallergic agent and a method of deriving it |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3398151A (en) * | 1966-02-01 | 1968-08-20 | Mead Johnson & Co | Azaspirodecanediones and azaspiroundecanediones |
| BE759371A (fr) * | 1969-11-24 | 1971-05-24 | Bristol Myers Co | Azaspirodecanediones heterocycliques et procedes pour leur preparation |
| US3976776A (en) * | 1972-12-06 | 1976-08-24 | Mead Johnson & Company | Tranquilizer process employing N-(heteroarcyclic)piperazinylalkylazaspiroalkanediones |
| US4182763A (en) * | 1978-05-22 | 1980-01-08 | Mead Johnson & Company | Buspirone anti-anxiety method |
| AU521110B2 (en) * | 1978-06-20 | 1982-03-18 | Synthelabo | Phenylpiperazine derivatives |
| US4305944A (en) * | 1980-09-08 | 1981-12-15 | Mead Johnson & Company | N-[(4-[3-cyano substituted pyridyl]piperazino)alkyl]-azaspirodecanediones |
-
1981
- 1981-12-28 US US06/334,689 patent/US4361565A/en not_active Expired - Fee Related
-
1982
- 1982-11-19 ZA ZA828546A patent/ZA828546B/xx unknown
- 1982-11-22 CA CA000416080A patent/CA1237722A/en not_active Expired
- 1982-12-02 AU AU91084/82A patent/AU560667B2/en not_active Ceased
- 1982-12-03 KR KR8205431A patent/KR880002011B1/ko active
- 1982-12-08 GR GR70020A patent/GR77101B/el unknown
- 1982-12-22 IT IT49720/82A patent/IT1158040B/it active
- 1982-12-23 DK DK573282A patent/DK162284C/da active
- 1982-12-23 JP JP57225099A patent/JPS58118583A/ja active Granted
- 1982-12-23 IE IE3068/82A patent/IE54620B1/en not_active IP Right Cessation
- 1982-12-23 AT AT0467682A patent/AT380880B/de not_active Expired
- 1982-12-23 FI FI824443A patent/FI70892C/fi not_active IP Right Cessation
- 1982-12-23 CY CY137882A patent/CY1378A/xx unknown
- 1982-12-23 GB GB08236592A patent/GB2114121B/en not_active Expired
- 1982-12-23 ES ES518511A patent/ES518511A0/es active Granted
- 1982-12-23 NL NL8204974A patent/NL8204974A/nl unknown
- 1982-12-24 FR FR8221751A patent/FR2518994B1/fr not_active Expired
- 1982-12-27 DE DE19823248138 patent/DE3248138A1/de active Granted
- 1982-12-27 SE SE8207426A patent/SE449748B/sv not_active IP Right Cessation
- 1982-12-27 CH CH7565/82A patent/CH653682A5/de not_active IP Right Cessation
- 1982-12-27 PT PT76037A patent/PT76037B/pt not_active IP Right Cessation
- 1982-12-27 HU HU824172A patent/HU190827B/hu not_active IP Right Cessation
- 1982-12-28 BE BE0/209827A patent/BE895505A/fr not_active IP Right Cessation
- 1982-12-29 LU LU84562A patent/LU84562A1/fr unknown
-
1987
- 1987-03-27 SG SG296/87A patent/SG29687G/en unknown
- 1987-03-31 KE KE3714A patent/KE3714A/xx unknown
-
1988
- 1988-01-21 HK HK51/88A patent/HK5188A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES513366A0 (es) | Un procedimiento para la preparacion de nuevas n-aril-piperazin alcanamidas. | |
| ES515889A0 (es) | Un procedimiento para la preparacion de compuestos. | |
| ES510449A0 (es) | Un procedimiento para la preparacion de 1,2,4-triazolonas.fenoxial-quilicas. | |
| ES517542A0 (es) | Un procedimiento para la preparacion de derivados de 3-hidroxi-ml-236-b. | |
| ES510696A0 (es) | Un procedimiento para la preparacion de nuevos tiojenos o furanos. | |
| ES511123A0 (es) | Un procedimiento para la preparacion de un dihidroxi-compuesto. | |
| ES512561A0 (es) | Un procedimiento para la preparacion de un eter 2-hidroxi-3-alcoxi-propilglicerilico. | |
| ES518511A0 (es) | Un procedimiento para la preparacion de compuestos dotados de propiedades psicotropicas. | |
| ES511124A0 (es) | Un procedimiento para la preparacion de un dihidroxi-compuesto. | |
| ES517222A0 (es) | Un procedimiento para la preparacion de derivados de acilmorrfinano. | |
| ES512880A0 (es) | Un procedimiento para la preparacion de derivados de 4-anilino-pirimidina. | |
| ES514264A0 (es) | Un procedimiento para la preparacion de derivados de tiazolidi-nilalquilen-piperazinas. | |
| ES509437A0 (es) | Un procedimiento para la preparacion de derivados carbapenen-2-tio-sustituidos. | |
| ES511663A0 (es) | Un procedimiento para la preparacion de un heteropoliacido. | |
| ES513880A0 (es) | Un procedimiento para la preparacion de derivados de triazolurea. | |
| ES514311A0 (es) | Un procedimiento para la preparacion de benzofurasulfamatos. | |
| ES510354A0 (es) | Un procedimiento para la preparacion de 2,3-dicloro-5-triclorometilpiridina. | |
| ES510067A0 (es) | Un procedimiento para la preparacion de nuevos derivados de benzoilurea. | |
| ES509312A0 (es) | Un procedimiento para la preparacion de 1-3-hidroxi-4-metoxibenzoil-3-hidroxi-2-pirrolidinona. | |
| ES511665A0 (es) | Un procedimiento para la preparacion de fenilaminoimidazolidinas. | |
| ES522386A0 (es) | Un procedimiento para la preparacion de derivados de benzotiazolina. | |
| ES509432A0 (es) | Un procedimiento para la preparacion de arilaminas. | |
| ES513967A0 (es) | Un procedimiento para la preparacion de derivados de etanola-mina. | |
| ES510611A0 (es) | Un procedimiento para la preparacion de derivados de desoxiuridina. | |
| ES521152A0 (es) | Un procedimiento para la preparacion de glutation. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD1A | Patent lapsed |
Effective date: 19970401 |